Higher heart rate increases risk of diabetes among men: The Australian Diabetes Obesity and Lifestyle (AusDiab) study

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages 421-427

  Grantham, N M ^a   Magliano, D J ^a   Tanamas, Stephanie K ^a   Soderberg S ^a,b   Schlaich, M P ^a   Shaw, J E ^a  

^a MONASH UNIVERSITY   (Australia)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE;

ADULT; ANTHROPOMETRY; ARTICLE; AUSTRALIAN; BLOOD SAMPLING; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART RATE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; QUESTIONNAIRE; RISK FACTOR; URINE SAMPLING; WORLD HEALTH ORGANIZATION; AGED; AUSTRALIA; COMPARATIVE STUDY; EPIDEMIOLOGY; GLUCOSE TOLERANCE TEST; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX DIFFERENCE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; VICTORIA;

EID: 84883544143     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12045     Document Type: Article

References (32)

1. Perret-Guillaume C, Joly L, Benetos A. Heart rate as a risk factor for cardiovascular disease. Prog Cardiovasc Dis 2009; 52: 6–10.
2. Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376: 886–894.
3. Carnethon MR, Yan L, Greenland P, Garside DB, Dyer AR, Metzger B et al. Resting heart rate in middle age and diabetes development in older age. Diabetes Care 2008; 31: 335–339.
4. Nagaya T, Yoshida H, Takahashi H, Kawai M. Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type 2 diabetes mellitus. Int J Epidemiol 2009; 39: 215– 222.
5. Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22: 151–155.
6. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987–1998. Circulation 2003; 107: 2190– 2195.
7. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 2000; 43: 561–570.
8. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 2002; 57: 119–129.
9. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008; 31: 267–272.
10. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of WHO/IDF Consultation. Geneva: World Health Organization, 2006.
11. Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, McNeil JJ et al. Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 179: 135–139.
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
13. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487–1495.
14. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH et al. Nephropathy in diabetes. Diabetes Care 2004; 27: S79–83.
15. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–2100.
16. Polkinghorne KR, Su Q, Chadban SJ, Shaw JE, Zimmet PZ, Atkins RC. Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis 2006; 47: 604–613.
17. WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva: World Health Organization, 1999.
18. Australian Institute of Health and Welfare. The Active Australia Survey: A Guide and Manual for Implementation, Analysis and Reporting. Canberra: Australian Insitute of Health and Welfare, 2003.
19. Australian Institute of Health and Welfare. Standard Questions on the Use of Tobacco Among Adults. Canberra: Australian Institute of Health and Welfare, 1998.
20. Landsberg L. Insulin resistance and the metabolic syndrome. Diabetologia 2005; 48: 1244–1246.
21. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21: 618–623.
22. Grassi G, Dell’Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363–2369.
23. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 787–796.
24. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14: 177–183.
25. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003; 108: 3097–3101.
26. Grassi G, Seravalle G, Dell’Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36: 538–542.
27. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621–627.
28. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, non-obese Japanese population. Am J Hypertens 1997; 10: 77–83.
29. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007; 25: 1411– 1419.
30. Hogarth AJ, Mackintosh AF, Mary DA. Gender-related differences in the sympathetic vasoconstrictor drive of normal subjects. Clin Sci (Lond) 2007; 112: 353–361.
31. Narkiewicz K, Somers VK. Interactive effect of heart rate and muscle sympathetic nerve activity on blood pressure. Circulation 1999; 100: 2514–2518.
32. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003; 285: H2188–2193.